{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:10:30Z","timestamp":1783336230139,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Rheumatoid arthritis is a chronic autoimmune disorder characterized by joint destruction and inflammation. Persistent pain is a common symptom, often impacting quality of life, physical function, and mental health. Despite its prevalence, limited guidance exists for managing chronic rheumatoid arthritis-related pain. This systematic review and meta-analysis aimed to evaluate the effectiveness of various analgesic therapies for managing rheumatoid arthritis-related pain symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A comprehensive search of PubMed, EMBASE, Cochrane, and ClinicalTrials.gov was conducted from database inception through November 7, 2024. Eligible studies included randomized controlled trials and prospective cohorts reporting pain outcomes in adult rheumatoid arthritis patients. Pain score data was stratified by scale (5-point, 10-point, 100-point) and analyzed using a random-effects model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-six studies covering 52 treatment regimens were included. Etodolac demonstrated significant pain reduction on a 5-point scale (200\u00a0mg: 3.24; 95% CI: 2.86 to 3.63; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; 300\u00a0mg: 3.35; 95% CI: 2.96 to 3.74; <jats:italic>p<\/jats:italic>\u2009=\u20090.00). Piroxicam also showed benefit (20\u00a0mg: 3.35; 95% CI: 2.91 to 3.78; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). On the 10-point scale, only extracorporeal shock wave therapy significantly reduced pain (3.36; 95% CI: 2.25 to 4.48; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Celecoxib (Celbesta) (200\u00a0mg BID) was most effective in the 100-point subgroup (1.73; 95% CI: 1.32 to 2.15; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Heterogeneity was high (I\u00b2 = 91.1%, 94.1%, 60.2%; all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and publication bias was present.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Several therapies demonstrated substantial pain relief, but heterogeneity, publication bias, and varying study quality limit generalizability. High-quality, long-term trials with standardized pain assessments are needed to guide personalized rheumatoid arthritis pain management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>PROSPERO CRD42024593971, 4 October 2024.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42358-025-00484-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:56:36Z","timestamp":1760702196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review and meta-analysis of analgesic treatment options in patients with rheumatoid arthritis related pain"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1614-002X","authenticated-orcid":false,"given":"Caleb","family":"Lautenschlager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashton","family":"Stropes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-6635","authenticated-orcid":false,"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-922X","authenticated-orcid":false,"given":"Maureen E.","family":"Knell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-6046","authenticated-orcid":false,"given":"Morgan","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"484_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.31138\/mjr.20230801.oo","volume":"34","author":"M Jahid","year":"2023","unstructured":"Jahid M, Khan KU, Rehan-Ul-Haq, Ahmed RS. Overview of rheumatoid arthritis and scientific Understanding of the disease. Mediterr J Rheumatol. 2023;34:284.","journal-title":"Mediterr J Rheumatol"},{"key":"484_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/jcm12041291","volume":"12","author":"Y Cai","year":"2023","unstructured":"Cai Y, et al. The burden of rheumatoid arthritis: findings from the 2019 global burden of diseases study and forecasts for 2030 by bayesian Age-Period-Cohort analysis. J Clin Med. 2023;12:1291.","journal-title":"J Clin Med"},{"key":"484_CR3","unstructured":"Arthritis foundation. Rheumatoid Arthritis: symptoms, diagnosis, and treatment. 2021. Available from: https:\/\/www.arthritis.org\/diseases\/rheumatoid-arthritis"},{"key":"484_CR4","unstructured":"World health organization. Rheumatoid arthritis. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rheumatoid-arthritis"},{"key":"484_CR5","unstructured":"Cleveland Clinic. What is Rheumatoid Arthritis (RA)?. 2024. Available from: https:\/\/my.clevelandclinic.org\/health\/diseases\/4924-rheumatoid-arthritis"},{"issue":"6","key":"484_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2217\/ijr.11.62","volume":"6","author":"M Margaretten","year":"2011","unstructured":"Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol. 2011;6(6):617\u201323.","journal-title":"Int J Clin Rheumatol"},{"issue":"7","key":"484_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924\u201339.","journal-title":"Arthritis Care Res"},{"key":"484_CR8","doi-asserted-by":"publisher","first-page":"b702","DOI":"10.1136\/bmj.b702","volume":"338","author":"C Deighton","year":"2009","unstructured":"Deighton C, O\u2019Mahony R, Tosh J, Turner C, Rudolf M. Management of rheumatoid arthritis: summary of NICE guidance. BMJ. 2009;338:b702.","journal-title":"BMJ"},{"key":"484_CR9","volume-title":"StatPearls [Internet]","author":"K Chauhan","year":"2025","unstructured":"Chauhan K, Jandu JS, Brent LH, Al-Dhahir MA. Rheumatoid arthritis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025."},{"issue":"3","key":"484_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/BOR.0000000000000602","volume":"31","author":"AL Day","year":"2019","unstructured":"Day AL, Curtis JR. Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices. Curr Opin Rheumatol. 2019;31(3):264\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"484_CR11","doi-asserted-by":"publisher","first-page":"300060520931323","DOI":"10.1177\/0300060520931323","volume":"48","author":"H-S Kim","year":"2020","unstructured":"Kim H-S, et al. Comparison of the efficacy and safety of CELBESTA\u00ae versus CELEBREX\u00ae in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial. J Int Med Res. 2020;48(3):300060520931323.","journal-title":"J Int Med Res"},{"key":"484_CR12","first-page":"10","volume":"47","author":"R Lightfoot","year":"1997","unstructured":"Lightfoot R. Comparison of the efficacy and safety of Etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac study 326 rheumatoid arthritis investigators group. J Rheumatol Suppl. 1997;47:10\u20136.","journal-title":"J Rheumatol Suppl"},{"issue":"5","key":"484_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2125.1989.tb03423.x","volume":"27","author":"SJ Preston","year":"1989","unstructured":"Preston SJ, Arnold MH, Beller EM, Brooks PM, Buchanan WW. Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. Br J Clin Pharmacol. 1989;27(5):607\u201311.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"484_CR14","first-page":"38","volume":"13","author":"MF de Queiros","year":"1991","unstructured":"de Queiros MF. Double-blind comparison of Etodolac and Naproxen in the treatment of rheumatoid arthritis. Clin Ther. 1991;13(1):38\u201346.","journal-title":"Clin Ther"},{"issue":"6","key":"484_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1185\/03007998509109614","volume":"9","author":"EM Grace","year":"1985","unstructured":"Grace EM, Bellamy N, Kassam Y, Buchanan WW. Controlled, double-blind randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr Med Res Opin. 1985;9(6):426\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"5889","key":"484_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.4.5884.82","volume":"4","author":"SB Mills","year":"1973","unstructured":"Mills SB, Bloch M, Bruckner FE. Double-blind cross-over study of ketoprofen and ibuprofen in management of rheumatoid arthritis. Br Med J. 1973;4(5889):82\u20134.","journal-title":"Br Med J"},{"issue":"8","key":"484_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1185\/03007998709108963","volume":"10","author":"CD Waltham-Weeks","year":"1987","unstructured":"Waltham-Weeks CD. Etodolac versus Naproxen in rheumatoid arthritis: a double-blind crossover study. Curr Med Res Opin. 1987;10(8):540\u20137.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"484_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000141929","volume":"15","author":"M Bernateck","year":"2008","unstructured":"Bernateck M, et al. Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: A randomized controlled trial. Forsch Komplementmed. 2008;15(1):2\u20132.","journal-title":"Forsch Komplementmed"},{"issue":"7","key":"484_CR19","first-page":"1643","volume":"27","author":"AC Chalmers","year":"2000","unstructured":"Chalmers AC, Busby C, Goyert J, Porter B, Schulzer M. Metatarsalgia and rheumatoid arthritis\u2013a randomized, single blind, sequential trial comparing 2 types of foot orthoses and supportive shoes. J Rheumatol. 2000;27(7):1643\u20137.","journal-title":"J Rheumatol"},{"issue":"3","key":"484_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/papr.12608","volume":"18","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhang T, Feng Y. Radial extracorporeal shock wave therapy for relief of arthralgia in rheumatoid arthritis. Pain Pract. 2018;18(3):380\u20137.","journal-title":"Pain Pract"},{"issue":"1","key":"484_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3899\/jrheum.150550","volume":"43","author":"YC Lee","year":"2016","unstructured":"Lee YC, et al. Effect of Milnacipran on pain in patients with rheumatoid arthritis with widespread pain: A randomized blinded crossover trial. J Rheumatol. 2016;43(1):38\u201345.","journal-title":"J Rheumatol"},{"issue":"1","key":"484_CR22","first-page":"8","volume":"11","author":"EC Huskisson","year":"1991","unstructured":"Huskisson EC. Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Eur J Rheumatol Inflamm. 1991;11(1):8\u201312.","journal-title":"Eur J Rheumatol Inflamm"},{"issue":"1","key":"484_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00484-016-1201-4","volume":"61","author":"M Karag\u00fclle","year":"2017","unstructured":"Karag\u00fclle M, et al. Effect of spa therapy with saline balneotherapy on oxidant\/antioxidant status in patients with rheumatoid arthritis: a single-blind randomized controlled trial. Int J Biometeorol. 2017;61(1):169\u201380.","journal-title":"Int J Biometeorol"},{"issue":"1","key":"484_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5055\/jom.2010.0003","volume":"6","author":"W Raffaeli","year":"2010","unstructured":"Raffaeli W, et al. Oxycodone\/acetaminophen at low dosage: an alternative pain treatment for patients with rheumatoid arthritis. J Opioid Manag. 2010;6(1):40\u20136.","journal-title":"J Opioid Manag"},{"issue":"1","key":"484_CR25","first-page":"15","volume":"11","author":"S S\u00e1nchez Andrada","year":"1991","unstructured":"S\u00e1nchez Andrada S, Rodr\u00edguez Valverde V. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis. Eur J Rheumatol Inflamm. 1991;11(1):15\u201320.","journal-title":"Eur J Rheumatol Inflamm"},{"issue":"10","key":"484_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/rheumatology\/38.10.959","volume":"38","author":"G Ash","year":"1999","unstructured":"Ash G, Dickens CM, Creed FH, Jayson MI, Tomenson B. The effects of Dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology (Oxford). 1999;38(10):959\u201367.","journal-title":"Rheumatology (Oxford)"},{"key":"484_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12891-016-1170-0","volume":"17","author":"K Bickham","year":"2016","unstructured":"Bickham K, et al. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of rheumatoid arthritis in a double-blind, randomized controlled trial. BMC Musculoskelet Disord. 2016;17:331.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"484_CR28","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.3390\/nu13093050","volume":"13","author":"C-K Chang","year":"2021","unstructured":"Chang C-K, et al. Increased levels of Omega-3 fatty acids and DHA are linked to pain reduction in rheumatoid arthritis patients treated with Janus kinase inhibitors. Nutrients. 2021;13(9):3050.","journal-title":"Nutrients"},{"key":"484_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1471-2474-15-375","volume":"15","author":"IA Choi","year":"2014","unstructured":"Choi IA, et al. Comparison of the efficacy and safety profiles of a Pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial. BMC Musculoskelet Disord. 2014;15:375.","journal-title":"BMC Musculoskelet Disord"},{"key":"484_CR30","first-page":"41","volume":"36","author":"P Emery","year":"1992","unstructured":"Emery P, et al. Nabumetone compared with Naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients. J Rheumatol Suppl. 1992;36:41\u20137.","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"484_CR31","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1185\/03007995.2011.614935","volume":"27","author":"M Greenwald","year":"2011","unstructured":"Greenwald M, et al. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. Curr Med Res Opin. 2011;27(10):2033\u201342.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"484_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1177\/0091270009355813","volume":"50","author":"S Kawai","year":"2010","unstructured":"Kawai S, et al. Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. J Clin Pharmacol. 2010;50(10):1171\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"484_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.23715","volume":"59","author":"E Keystone","year":"2008","unstructured":"Keystone E, et al. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum. 2008;59(6):785\u201393.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"484_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00002508-199903000-00009","volume":"15","author":"E Leibing","year":"1999","unstructured":"Leibing E, Pfingsten M, Bartmann U, Rueger U, Schuessler G. Cognitive-behavioral treatment in unselected rheumatoid arthritis outpatients. Clin J Pain. 1999;15(1):58\u201366.","journal-title":"Clin J Pain"},{"issue":"4","key":"484_CR35","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.clinthera.2007.05.006","volume":"29","author":"YW Song","year":"2007","unstructured":"Song YW, et al. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. Clin Ther. 2007;29(4):862\u201373.","journal-title":"Clin Ther"},{"issue":"6","key":"484_CR36","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/14397595.2016.1270496","volume":"27","author":"CC Wang","year":"2017","unstructured":"Wang CC, Lee SH, Lin HY, Liu FW, Chiou HJ, Chan RC, et al. Short-term effect of ultrasound-guided low-molecular-weight hyaluronic acid injection on clinical outcomes and imaging changes in patients with rheumatoid arthritis of the ankle and foot joints. A randomized controlled pilot trial. Mod Rheumatol. 2017;27(6):973\u201380.","journal-title":"Mod Rheumatol"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00484-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:56:41Z","timestamp":1760702201000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00484-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00484-1","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}